Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 4;14(19):1693-1700.
doi: 10.1002/cmdc.201900428. Epub 2019 Sep 23.

Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for Chordoma

Affiliations

Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for Chordoma

Christopher R M Asquith et al. ChemMedChem. .

Abstract

Quinoline- and quinazoline-based kinase inhibitors of the epidermal growth factor receptor (EGFR) have been used to target non-small cell lung cancer (NSCLC) and chordomas with varying amounts of success. We designed and prepared compounds to probe several key structural features including an interaction with Asp855 within the EGFR DGF motif and interactions with the active site water network. EGFR target engagement was then evaluated in a cellular assay, with the inhibitors then profiled in representative cellular models of NSCLC and chordomas. In addition, structure-activity relationship insight into EGFR inhibitor design with potent dimethoxyquin(az)olines identified compounds 1 [N-(3-ethynylphenyl)-6,7-dimethoxyquinolin-4-amine], 4 [N-(3-ethynylphenyl)-6,7-dimethoxyquinazolin-4-amine], and 7 [4-((3-ethynylphenyl)amino)-6,7-dimethoxyquinoline-3-carbonitrile]. We also identified 6,7-dimethoxy-N-(4-((4-methylbenzyl)oxy)phenyl)quinolin-4-amine (compound 18), which is the most potent inhibitor (IC50 =310 nm) of the UCH-2 chordoma cell line to date.

Keywords: 4-anilinoquinazolines; 4-anilinoquinolines; chordoma; epidermal growth factor receptor (EGFR); non-small cell lung cancer (NSCLC).

PubMed Disclaimer

References

    1. Cancer Fact Sheet No. 297, World Health Organization, 2018: https://www.who.int/news-room/fact-sheets/detail/cancer.
    1. None
    1. F. M. Ferguson, N. S. Gray, Nat. Rev. Drug Discovery 2018, 17, 353-377;
    1. FDA-approved small-molecule protein kinase inhibitors, Blue Ridge Institute for Medical Research, Horse Shoe, NC (USA): http://www.brimr.org/PKI/PKIs.htm.
    1. T. J. Lynch, D. W. Bell, R. Sordella, S. Gurubhagavatula, R. A. Okimoto, B. W. Brannigan, P. L. Harris, S. M. Haserlat, J. G. Supko, F. G. Haluska, D. N. Louis, D. C. Christiani, J. Settleman, D. A. Haber, N. Engl. J. Med. 2004, 350, 2129-2139.

MeSH terms

LinkOut - more resources